Report cover image

Global Prostaglandin Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Jul 16, 2025
Length 198 Pages
SKU # APRC20280580

Description

Summary

According to APO Research, the global Prostaglandin market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Prostaglandin is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Asia-Pacific market for Prostaglandin is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Prostaglandin market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Europe market for Prostaglandin is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Prostaglandin market include AUSUN Pharmaceutical, Everlight Chemical, Sanofi CEPiA, Chirogate, Yonsung Fine Chemicals, Kyowa Hakko Pharma, Johnson Matthey, Cayman Chemical and Aspen Biopharma Labs, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Prostaglandin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Prostaglandin, also provides the sales of main regions and countries. Of the upcoming market potential for Prostaglandin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Prostaglandin sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Prostaglandin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Prostaglandin sales, projected growth trends, production technology, application and end-user industry.

Prostaglandin Segment by Company

AUSUN Pharmaceutical
Everlight Chemical
Sanofi CEPiA
Chirogate
Yonsung Fine Chemicals
Kyowa Hakko Pharma
Johnson Matthey
Cayman Chemical
Aspen Biopharma Labs
ANVI Pharma
Prostaglandin Segment by Type

Human Prostaglandin
Veterinary Prostaglandin
Prostaglandin Segment by Application

Gynecological and Obstetrical
Cardiovascular
Ophthalmologic
Other
Prostaglandin Segment by Region

North America

United States
Canada
Europe

Germany
France
U.K.
Italy
Netherlands
Asia-Pacific

China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America

Mexico
Brazil
Argentina
Colombia
Middle East & Africa

Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Prostaglandin status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Prostaglandin market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Prostaglandin significant trends, drivers, influence factors in global and regions.
6. To analyze Prostaglandin competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prostaglandin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Prostaglandin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prostaglandin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Prostaglandin market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Prostaglandin industry.
Chapter 3: Detailed analysis of Prostaglandin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Prostaglandin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Prostaglandin in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

198 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Prostaglandin Sales Value (2020-2031)
1.2.2 Global Prostaglandin Sales Volume (2020-2031)
1.2.3 Global Prostaglandin Sales Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Prostaglandin Market Dynamics
2.1 Prostaglandin Industry Trends
2.2 Prostaglandin Industry Drivers
2.3 Prostaglandin Industry Opportunities and Challenges
2.4 Prostaglandin Industry Restraints
3 Prostaglandin Market by Company
3.1 Global Prostaglandin Company Revenue Ranking in 2024
3.2 Global Prostaglandin Revenue by Company (2020-2025)
3.3 Global Prostaglandin Sales Volume by Company (2020-2025)
3.4 Global Prostaglandin Average Price by Company (2020-2025)
3.5 Global Prostaglandin Company Ranking (2023-2025)
3.6 Global Prostaglandin Company Manufacturing Base and Headquarters
3.7 Global Prostaglandin Company Product Type and Application
3.8 Global Prostaglandin Company Establishment Date
3.9 Market Competitive Analysis
3.9.1 Global Prostaglandin Market Concentration Ratio (CR5 and HHI)
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.9.3 2024 Prostaglandin Tier 1, Tier 2, and Tier 3 Companies
3.10 Mergers and Acquisitions Expansion
4 Prostaglandin Market by Type
4.1 Prostaglandin Type Introduction
4.1.1 Human Prostaglandin
4.1.2 Veterinary Prostaglandin
4.2 Global Prostaglandin Sales Volume by Type
4.2.1 Global Prostaglandin Sales Volume by Type (2020 VS 2024 VS 2031)
4.2.2 Global Prostaglandin Sales Volume by Type (2020-2031)
4.2.3 Global Prostaglandin Sales Volume Share by Type (2020-2031)
4.3 Global Prostaglandin Sales Value by Type
4.3.1 Global Prostaglandin Sales Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Prostaglandin Sales Value by Type (2020-2031)
4.3.3 Global Prostaglandin Sales Value Share by Type (2020-2031)
5 Prostaglandin Market by Application
5.1 Prostaglandin Application Introduction
5.1.1 Gynecological and Obstetrical
5.1.2 Cardiovascular
5.1.3 Ophthalmologic
5.1.4 Other
5.2 Global Prostaglandin Sales Volume by Application
5.2.1 Global Prostaglandin Sales Volume by Application (2020 VS 2024 VS 2031)
5.2.2 Global Prostaglandin Sales Volume by Application (2020-2031)
5.2.3 Global Prostaglandin Sales Volume Share by Application (2020-2031)
5.3 Global Prostaglandin Sales Value by Application
5.3.1 Global Prostaglandin Sales Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Prostaglandin Sales Value by Application (2020-2031)
5.3.3 Global Prostaglandin Sales Value Share by Application (2020-2031)
6 Prostaglandin Regional Sales and Value Analysis
6.1 Global Prostaglandin Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Prostaglandin Sales by Region (2020-2031)
6.2.1 Global Prostaglandin Sales by Region: 2020-2025
6.2.2 Global Prostaglandin Sales by Region (2026-2031)
6.3 Global Prostaglandin Sales Value by Region: 2020 VS 2024 VS 2031
6.4 Global Prostaglandin Sales Value by Region (2020-2031)
6.4.1 Global Prostaglandin Sales Value by Region: 2020-2025
6.4.2 Global Prostaglandin Sales Value by Region (2026-2031)
6.5 Global Prostaglandin Market Price Analysis by Region (2020-2025)
6.6 North America
6.6.1 North America Prostaglandin Sales Value (2020-2031)
6.6.2 North America Prostaglandin Sales Value Share by Country, 2024 VS 2031
6.7 Europe
6.7.1 Europe Prostaglandin Sales Value (2020-2031)
6.7.2 Europe Prostaglandin Sales Value Share by Country, 2024 VS 2031
6.8 Asia-Pacific
6.8.1 Asia-Pacific Prostaglandin Sales Value (2020-2031)
6.8.2 Asia-Pacific Prostaglandin Sales Value Share by Country, 2024 VS 2031
6.9 South America
6.9.1 South America Prostaglandin Sales Value (2020-2031)
6.9.2 South America Prostaglandin Sales Value Share by Country, 2024 VS 2031
6.10 Middle East & Africa
6.10.1 Middle East & Africa Prostaglandin Sales Value (2020-2031)
6.10.2 Middle East & Africa Prostaglandin Sales Value Share by Country, 2024 VS 2031
7 Prostaglandin Country-level Sales and Value Analysis
7.1 Global Prostaglandin Sales by Country: 2020 VS 2024 VS 2031
7.2 Global Prostaglandin Sales Value by Country: 2020 VS 2024 VS 2031
7.3 Global Prostaglandin Sales by Country (2020-2031)
7.3.1 Global Prostaglandin Sales by Country (2020-2025)
7.3.2 Global Prostaglandin Sales by Country (2026-2031)
7.4 Global Prostaglandin Sales Value by Country (2020-2031)
7.4.1 Global Prostaglandin Sales Value by Country (2020-2025)
7.4.2 Global Prostaglandin Sales Value by Country (2026-2031)
7.5 USA
7.5.1 USA Prostaglandin Sales Value Growth Rate (2020-2031)
7.5.2 USA Prostaglandin Sales Value Share by Type, 2024 VS 2031
7.5.3 USA Prostaglandin Sales Value Share by Application, 2024 VS 2031
7.6 Canada
7.6.1 Canada Prostaglandin Sales Value Growth Rate (2020-2031)
7.6.2 Canada Prostaglandin Sales Value Share by Type, 2024 VS 2031
7.6.3 Canada Prostaglandin Sales Value Share by Application, 2024 VS 2031
7.7 Mexico
7.6.1 Mexico Prostaglandin Sales Value Growth Rate (2020-2031)
7.6.2 Mexico Prostaglandin Sales Value Share by Type, 2024 VS 2031
7.6.3 Mexico Prostaglandin Sales Value Share by Application, 2024 VS 2031
7.8 Germany
7.8.1 Germany Prostaglandin Sales Value Growth Rate (2020-2031)
7.8.2 Germany Prostaglandin Sales Value Share by Type, 2024 VS 2031
7.8.3 Germany Prostaglandin Sales Value Share by Application, 2024 VS 2031
7.9 France
7.9.1 France Prostaglandin Sales Value Growth Rate (2020-2031)
7.9.2 France Prostaglandin Sales Value Share by Type, 2024 VS 2031
7.9.3 France Prostaglandin Sales Value Share by Application, 2024 VS 2031
7.10 U.K.
7.10.1 U.K. Prostaglandin Sales Value Growth Rate (2020-2031)
7.10.2 U.K. Prostaglandin Sales Value Share by Type, 2024 VS 2031
7.10.3 U.K. Prostaglandin Sales Value Share by Application, 2024 VS 2031
7.11 Italy
7.11.1 Italy Prostaglandin Sales Value Growth Rate (2020-2031)
7.11.2 Italy Prostaglandin Sales Value Share by Type, 2024 VS 2031
7.11.3 Italy Prostaglandin Sales Value Share by Application, 2024 VS 2031
7.12 Spain
7.12.1 Spain Prostaglandin Sales Value Growth Rate (2020-2031)
7.12.2 Spain Prostaglandin Sales Value Share by Type, 2024 VS 2031
7.12.3 Spain Prostaglandin Sales Value Share by Application, 2024 VS 2031
7.13 Russia
7.13.1 Russia Prostaglandin Sales Value Growth Rate (2020-2031)
7.13.2 Russia Prostaglandin Sales Value Share by Type, 2024 VS 2031
7.13.3 Russia Prostaglandin Sales Value Share by Application, 2024 VS 2031
7.14 Netherlands
7.14.1 Netherlands Prostaglandin Sales Value Growth Rate (2020-2031)
7.14.2 Netherlands Prostaglandin Sales Value Share by Type, 2024 VS 2031
7.14.3 Netherlands Prostaglandin Sales Value Share by Application, 2024 VS 2031
7.15 Nordic Countries
7.15.1 Nordic Countries Prostaglandin Sales Value Growth Rate (2020-2031)
7.15.2 Nordic Countries Prostaglandin Sales Value Share by Type, 2024 VS 2031
7.15.3 Nordic Countries Prostaglandin Sales Value Share by Application, 2024 VS 2031
7.16 China
7.16.1 China Prostaglandin Sales Value Growth Rate (2020-2031)
7.16.2 China Prostaglandin Sales Value Share by Type, 2024 VS 2031
7.16.3 China Prostaglandin Sales Value Share by Application, 2024 VS 2031
7.17 Japan
7.17.1 Japan Prostaglandin Sales Value Growth Rate (2020-2031)
7.17.2 Japan Prostaglandin Sales Value Share by Type, 2024 VS 2031
7.17.3 Japan Prostaglandin Sales Value Share by Application, 2024 VS 2031
7.18 South Korea
7.18.1 South Korea Prostaglandin Sales Value Growth Rate (2020-2031)
7.18.2 South Korea Prostaglandin Sales Value Share by Type, 2024 VS 2031
7.18.3 South Korea Prostaglandin Sales Value Share by Application, 2024 VS 2031
7.19 India
7.19.1 India Prostaglandin Sales Value Growth Rate (2020-2031)
7.19.2 India Prostaglandin Sales Value Share by Type, 2024 VS 2031
7.19.3 India Prostaglandin Sales Value Share by Application, 2024 VS 2031
7.20 Australia
7.20.1 Australia Prostaglandin Sales Value Growth Rate (2020-2031)
7.20.2 Australia Prostaglandin Sales Value Share by Type, 2024 VS 2031
7.20.3 Australia Prostaglandin Sales Value Share by Application, 2024 VS 2031
7.21 Southeast Asia
7.21.1 Southeast Asia Prostaglandin Sales Value Growth Rate (2020-2031)
7.21.2 Southeast Asia Prostaglandin Sales Value Share by Type, 2024 VS 2031
7.21.3 Southeast Asia Prostaglandin Sales Value Share by Application, 2024 VS 2031
7.22 Brazil
7.22.1 Brazil Prostaglandin Sales Value Growth Rate (2020-2031)
7.22.2 Brazil Prostaglandin Sales Value Share by Type, 2024 VS 2031
7.22.3 Brazil Prostaglandin Sales Value Share by Application, 2024 VS 2031
7.23 Argentina
7.23.1 Argentina Prostaglandin Sales Value Growth Rate (2020-2031)
7.23.2 Argentina Prostaglandin Sales Value Share by Type, 2024 VS 2031
7.23.3 Argentina Prostaglandin Sales Value Share by Application, 2024 VS 2031
7.24 Chile
7.24.1 Chile Prostaglandin Sales Value Growth Rate (2020-2031)
7.24.2 Chile Prostaglandin Sales Value Share by Type, 2024 VS 2031
7.24.3 Chile Prostaglandin Sales Value Share by Application, 2024 VS 2031
7.25 Colombia
7.25.1 Colombia Prostaglandin Sales Value Growth Rate (2020-2031)
7.25.2 Colombia Prostaglandin Sales Value Share by Type, 2024 VS 2031
7.25.3 Colombia Prostaglandin Sales Value Share by Application, 2024 VS 2031
7.26 Peru
7.26.1 Peru Prostaglandin Sales Value Growth Rate (2020-2031)
7.26.2 Peru Prostaglandin Sales Value Share by Type, 2024 VS 2031
7.26.3 Peru Prostaglandin Sales Value Share by Application, 2024 VS 2031
7.27 Saudi Arabia
7.27.1 Saudi Arabia Prostaglandin Sales Value Growth Rate (2020-2031)
7.27.2 Saudi Arabia Prostaglandin Sales Value Share by Type, 2024 VS 2031
7.27.3 Saudi Arabia Prostaglandin Sales Value Share by Application, 2024 VS 2031
7.28 Israel
7.28.1 Israel Prostaglandin Sales Value Growth Rate (2020-2031)
7.28.2 Israel Prostaglandin Sales Value Share by Type, 2024 VS 2031
7.28.3 Israel Prostaglandin Sales Value Share by Application, 2024 VS 2031
7.29 UAE
7.29.1 UAE Prostaglandin Sales Value Growth Rate (2020-2031)
7.29.2 UAE Prostaglandin Sales Value Share by Type, 2024 VS 2031
7.29.3 UAE Prostaglandin Sales Value Share by Application, 2024 VS 2031
7.30 Turkey
7.30.1 Turkey Prostaglandin Sales Value Growth Rate (2020-2031)
7.30.2 Turkey Prostaglandin Sales Value Share by Type, 2024 VS 2031
7.30.3 Turkey Prostaglandin Sales Value Share by Application, 2024 VS 2031
7.31 Iran
7.31.1 Iran Prostaglandin Sales Value Growth Rate (2020-2031)
7.31.2 Iran Prostaglandin Sales Value Share by Type, 2024 VS 2031
7.31.3 Iran Prostaglandin Sales Value Share by Application, 2024 VS 2031
7.32 Egypt
7.32.1 Egypt Prostaglandin Sales Value Growth Rate (2020-2031)
7.32.2 Egypt Prostaglandin Sales Value Share by Type, 2024 VS 2031
7.32.3 Egypt Prostaglandin Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 AUSUN Pharmaceutical
8.1.1 AUSUN Pharmaceutical Comapny Information
8.1.2 AUSUN Pharmaceutical Business Overview
8.1.3 AUSUN Pharmaceutical Prostaglandin Sales, Value and Gross Margin (2020-2025)
8.1.4 AUSUN Pharmaceutical Prostaglandin Product Portfolio
8.1.5 AUSUN Pharmaceutical Recent Developments
8.2 Everlight Chemical
8.2.1 Everlight Chemical Comapny Information
8.2.2 Everlight Chemical Business Overview
8.2.3 Everlight Chemical Prostaglandin Sales, Value and Gross Margin (2020-2025)
8.2.4 Everlight Chemical Prostaglandin Product Portfolio
8.2.5 Everlight Chemical Recent Developments
8.3 Sanofi CEPiA
8.3.1 Sanofi CEPiA Comapny Information
8.3.2 Sanofi CEPiA Business Overview
8.3.3 Sanofi CEPiA Prostaglandin Sales, Value and Gross Margin (2020-2025)
8.3.4 Sanofi CEPiA Prostaglandin Product Portfolio
8.3.5 Sanofi CEPiA Recent Developments
8.4 Chirogate
8.4.1 Chirogate Comapny Information
8.4.2 Chirogate Business Overview
8.4.3 Chirogate Prostaglandin Sales, Value and Gross Margin (2020-2025)
8.4.4 Chirogate Prostaglandin Product Portfolio
8.4.5 Chirogate Recent Developments
8.5 Yonsung Fine Chemicals
8.5.1 Yonsung Fine Chemicals Comapny Information
8.5.2 Yonsung Fine Chemicals Business Overview
8.5.3 Yonsung Fine Chemicals Prostaglandin Sales, Value and Gross Margin (2020-2025)
8.5.4 Yonsung Fine Chemicals Prostaglandin Product Portfolio
8.5.5 Yonsung Fine Chemicals Recent Developments
8.6 Kyowa Hakko Pharma
8.6.1 Kyowa Hakko Pharma Comapny Information
8.6.2 Kyowa Hakko Pharma Business Overview
8.6.3 Kyowa Hakko Pharma Prostaglandin Sales, Value and Gross Margin (2020-2025)
8.6.4 Kyowa Hakko Pharma Prostaglandin Product Portfolio
8.6.5 Kyowa Hakko Pharma Recent Developments
8.7 Johnson Matthey
8.7.1 Johnson Matthey Comapny Information
8.7.2 Johnson Matthey Business Overview
8.7.3 Johnson Matthey Prostaglandin Sales, Value and Gross Margin (2020-2025)
8.7.4 Johnson Matthey Prostaglandin Product Portfolio
8.7.5 Johnson Matthey Recent Developments
8.8 Cayman Chemical
8.8.1 Cayman Chemical Comapny Information
8.8.2 Cayman Chemical Business Overview
8.8.3 Cayman Chemical Prostaglandin Sales, Value and Gross Margin (2020-2025)
8.8.4 Cayman Chemical Prostaglandin Product Portfolio
8.8.5 Cayman Chemical Recent Developments
8.9 Aspen Biopharma Labs
8.9.1 Aspen Biopharma Labs Comapny Information
8.9.2 Aspen Biopharma Labs Business Overview
8.9.3 Aspen Biopharma Labs Prostaglandin Sales, Value and Gross Margin (2020-2025)
8.9.4 Aspen Biopharma Labs Prostaglandin Product Portfolio
8.9.5 Aspen Biopharma Labs Recent Developments
8.10 ANVI Pharma
8.10.1 ANVI Pharma Comapny Information
8.10.2 ANVI Pharma Business Overview
8.10.3 ANVI Pharma Prostaglandin Sales, Value and Gross Margin (2020-2025)
8.10.4 ANVI Pharma Prostaglandin Product Portfolio
8.10.5 ANVI Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Prostaglandin Value Chain Analysis
9.1.1 Prostaglandin Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Prostaglandin Sales Mode & Process
9.2 Prostaglandin Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Prostaglandin Distributors
9.2.3 Prostaglandin Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.